Who Owns Silence Therapeutics Plc American Depository Share Stock?
NASDAQ: SLNHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 44.36%
- Held by insiders
- 7.97%
- Institutional holders
- 91
- Institutions 44.4%
- Insiders 8.0%
- Public and other 47.7%
Who owns Silence Therapeutics Plc American Depository Share stock?
Institutional investors own about 44.4% of Silence Therapeutics Plc American Depository Share's shares, spread across 91 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 7.97% of SLN.
The largest institutional holders are Siren, L.L.C. (5.50%), TCG Crossover Management, LLC (5.04%) and Redmile Group, LLC (3.60%). Together, the top 10 institutions control 25.4% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their SLN positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of SLN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Siren, L.L.C. | 3.31M | 5.50% | +13.7% |
| TCG Crossover Management, LLC | 3.03M | 5.04% | 0.0% |
| Redmile Group, LLC | 2.16M | 3.60% | 0.0% |
| Nantahala Capital Management, LLC | 1.35M | 2.24% | -37.3% |
| Citadel Advisors Llc | 1.33M | 2.21% | +7.7% |
| Nextech Invest, Ltd. | 952.40K | 1.58% | 0.0% |
| Millennium Management Llc | 909.28K | 1.51% | -15.3% |
| Ikarian Capital, LLC | 830.78K | 1.38% | -4.0% |
| Tetragon Partners GP Ltd. | 764.26K | 1.27% | +21.3% |
| Soleus Capital Management, L.P. | 630.00K | 1.05% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of SLN
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 531.79K | 0.88% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 500.00K | 0.83% |
| iShares Trust-iShares Biotechnology ETF | 234.01K | 0.39% |
| Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund | 228.00K | 0.38% |
| ALGER FUNDS-Alger Small Cap Growth Fund | 105.68K | 0.18% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 103.91K | 0.17% |
| Variable Insurance Products Fund IV-VIP Health Care Portfolio | 85.00K | 0.14% |
| ALGER INSTITUTIONAL FUNDS-Alger Small Cap Growth Institutional Fund | 41.29K | 0.07% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 29.54K | 0.05% |
| SPDR INDEX SHARES Fd.S-State Street SPDR S&P Intl Small Cap ETF | 9.58K | 0.02% |
Frequently asked questions
Who is the largest shareholder of Silence Therapeutics Plc American Depository Share?
Siren, L.L.C. is the largest institutional shareholder of SLN, owning 5.50% of shares outstanding (3.31M shares) as of its latest 13F filing.
What percentage of Silence Therapeutics Plc American Depository Share is owned by institutions?
Institutions own about 44.4% of SLN shares and 48.2% of the public float.
How much of Silence Therapeutics Plc American Depository Share do insiders own?
Insiders, such as officers and directors, own about 7.97% of SLN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.